AGIO · Healthcare · $2.0B
$33.25-0.15%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“AQVESME(아크베스미)의 미국 출시가 순조롭게 시작됐어요.”
In the company's words · 2026 1분기 earnings call